Abstract
GABAergic activity is regulated by rapid, high affinity uptake of GABA from the synapse. Perturbation of GABA reuptake has been implicated in neurological disease and inhibitors of GABA transporters (GAT) have been used therapeutically but little detail is known about the ramifications of GAT inhibition on brain neurochemistry. Here, we incubated Guinea pig cortical tissue slices with [3-13C]pyruvate and major, currently available GABA uptake inhibitors. Metabolic fingerprints were generated from these experiments using 13C/1H NMR spectroscopy. These fingerprints were analyzed using multivariate statistical approaches and compared with an existing library of fingerprints of activity at GABA receptors. This approach identified five distinct clusters of metabolic activity induced by blocking GABA uptake. Inhibition of GABA uptake via GAT1 produced patterns similar to activity at mainstream GABAergic synapses in particular those containing α1-subunits but still statistically separable. This indicated that inhibition of GABA uptake, an indirect method of activating GABA receptors, produces different effects to direct receptor activation or to exogenous GABA. The mechanism of inhibitor function also produced different outcomes, with the channel blocker SKF 89976A yielding a unique metabolic response. Blocking GAT1 and GAT3 simultaneously induces a large metabolic response consistent with induction of tonic inhibition via high affinity GABA receptors. Blocking BGT produces patterns similar to activity at less common receptors such as those containing α5 subunits. This approach is useful for determining where in the spectrum of GABAergic responses a particular GABA transport inhibitor is effective.
Similar content being viewed by others
References
Borden, L. A., Dhar, T. G., Smith, K. E., Branchek, T. A., Gluchowski, C., & Weinshank, R. L. (1994). Cloning of the human homologue of the GABA transporter GAT-3 and identification of a novel inhibitor with selectivity for this site. Receptors and Channels, 2, 207–213.
Borden, L. A., Smith, K. E., Gustafson, E. L., Branchek, T. A., & Weinshank, R. L. (1995). Cloning and expression of a betaine/GABA transporter from human brain. Journal of Neurochemistry, 64, 977–984.
Bröer, S., Bröer, A., Hansen, J. T., Bubb, W. A., Balcar, V. J., Nasrallah, F. A., et al. (2007). Alanine metabolism, transport and cycling in the brain. Journal of Neurochemistry, 102, 1758–1770.
Broer, S., Broer, A., Schneider, H. P., Stegen, C., Halestrap, A. P., & Deitmer, J. W. (1999). Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes. Biochemical Journal, 341, 529–535.
Bröer, S., & Brookes, N. (2001). Transfer of glutamine between astrocytes and neurons. Journal of Neurochemistry, 77, 705–719.
Cammack, J. N., & Schwartz, E. A. (1996). Channel behavior in a gamma-aminobutyrate transporter. Proceedings of the National Academy of Sciences of the United States of America, 93, 723–727.
Chatton, J. Y., Pellerin, L., & Magistretti, P. J. (2003). GABA uptake into astrocytes is not associated with significant metabolic cost: Implications for brain imaging of inhibitory transmission. Proceedings of the National Academy of Sciences of the United States of America, 100, 12456–12461.
Conti, F., Minelli, A., & Melone, M. (2004). GABA transporters in the mammalian cerebral cortex: Localization, development and pathological implications. Brain Research Reviews, 45, 196–212.
Coomans, D., Broeckaert, I., Derde, M. P., Tassin, A., Massart, D. L., & Wold, S. (1984). Use of a microcomputer for the definition of multivariate confidence regions in medical diagnosis based on clinical laboratory profiles. Computers and Biomedical Research, 17, 1–14.
Dalby, N. O. (2000). GABA level increasing and anticonvulsant effects of three different GABA uptake inhibitors. Neuropharmacology, 39, 2399–2407.
Dalby, N. O. (2003). Inhibition of γ-aminobutyric acid uptake: Anatomy, physiology and effects against epileptic seizures. European Journal of Pharmacology, 479, 127–137.
Dericioglu, N., Garganta, C. L., Petroff, O. A., Mendelsohn, D., & Williamson, A. (2008). Blockade of GABA synthesis only affects neural excitability under activated conditions in rat hippocampal slices. Neurochemistry International, 53, 22–32.
Dienel, G. A., & Cruz, N. F. (2009). Exchange-mediated dilution of brain lactate specific activity: Implications for the origin of glutamate dilution and the contributions of glutamine dilution and other pathways. Journal of Neurochemistry, 109(s1), 30–37.
Farrant, M., & Nusser, Z. (2005). Variations on an inhibitory theme: Phasic and tonic activation of GABAA receptors. Nature Reviews. Neuroscience, 6, 215–229.
Galvan, A., Villalba, R. M., West, S. M., Maidment, N. T., Ackerson, L. C., Smith, Y., et al. (2005). GABAergic modulation of the activity of globus pallidus neurons in primates: In vivo analysis of the functions of GABA receptors and GABA transporters. Journal of Neurophysiology, 94, 990–1000.
Giusti, P., Guidotti, A., Wojciech, D., Auta, J., & Costa, E. (1990). Neuropharmacological evidence for an interaction between the GABA uptake inhibitor Cl-966 and anxiolytic benzodiazepines. Drug Development Research, 21, 217–225.
Griffin, J. L., Keun, H., Moskau, D., Rae, C., & Nicholson, J. K. (2003). Compartmentation of metabolism probed by [2-13C]alanine: Improved 13C NMR sensitivity using a CryoProbe detects evidence of a glial metabolon. Neurochemistry International, 42, 93–99.
Griffin, J. L., Rae, C., Dixon, R. M., Radda, G. K., & Matthews, P. M. (1998). Excitatory amino acid synthesis in hypoxic brain slices: Does alanine act as a substrate for glutamate production in hypoxia? Journal of Neurochemistry, 71, 2477–2486.
Iversen, L. (2006). Neurotransmitter transporter and their impact on the development of psychopharmacology. British Journal of Pharmacology, 147, s82–s88.
Keros, S., & Hablitz, J. J. (2005). Subtype-specific GABA transporter antagonists synergistically modulate phasic and tonic GABA(A) conductances in rat neocortex. Journal of Neurophysiology, 94, 2073–2085.
Kinney, G. A. (2005). GAT-3 transporters regulate inhibition in the neocortex. Journal of Neurophysiology, 94, 4533–4537.
Krause, S., & Schwarz, W. (2005). Identification and selective inhibition of the channel mode of the neuronal GABA transporter 1. Molecular Pharmacology, 68, 1728–1735.
LaRoche, S. M., & Helmers, S. L. (2004). The new antiepileptic drugs. Journal of the American Medical Association, 291, 605–614.
Le Belle, J. E., Harris, N. G., Williams, S. R., & Bhakoo, K. K. (2002). A comparison of cell and tissue extraction techniques using high-resolution 1H NMR spectroscopy. NMR in Biomedicine, 15, 37–44.
Lodge, D., Curtis, D. R., & Johnston, G. A. R. (1978). Does uptake limit the action of GABA agonists in vivo? Experiments with muscimol, isoguvacine and THIP in car spinal cord. Journal of Neurochemistry, 31, 1525–1528.
Madsen, K. K., Clausen, R. P., Larsson, O. M., Krogsgaard-Larsen, P., Schousboe, A., & Steve White, H. (2008). Synaptic and extrasynaptic GABA transporters as targets for anti-epileptic drugs (pp. 139–144). Beijing: Wiley-Blackwell Publishing, Inc., 2008 Jun 27–Jul 01.
Matskevitch, I., Wagner, C. A., Stegen, C., Broer, S., Noll, B., Risler, T., et al. (1999). Functional characterization of the betaine/gamma-aminobutyric acid transporter BGT-1 expressed in Xenopus oocytes. Journal of Biological Chemistry, 274, 16709–16716.
McIlwain, H., & Bachelard, H. (1985). Biochemistry and the central nervous system. Edinburgh: Churchill Livingstone.
Minelli, A., DeBiasi, S., Brecha, N. C., Zuccarello, L. V., & Conti, F. (1996). GAT-3, a high affinity GABA plasma membrane transporter, is localized to astrocytic processes, and it is not confined to the vicinity of GABAergic synapses in the cerebral cortex. Journal of Neuroscience, 16, 6255–6264.
Mody, I. (2001). Distinguishing between GABA(A) receptors responsible for tonic and phasic conductances. Neurochemical Research, 26, 907–913.
Möhler, H. (2006). GABAA receptor diversity and pharmacology. Cell and Tissue Research, 326, 505–516.
Moussa, C. E.-H., Rae, C., Bubb, W. A., Griffin, J. L., Deters, N. A., & Balcar, V. J. (2007). Inhibitors of glutamate transport modulate distinct patterns in brain metabolism. Journal of Neuroscience Research, 85, 342–350.
Nasrallah, F., Griffin, J. L., Balcar, V. J., & Rae, C. (2007). Understanding your inhibitions. Modulation of brain cortical metabolism by GABA-B receptors. Journal of Cerebral Blood Flow and Metabolism, 27, 1510–1520.
Overstreet, L. S., & Westbrook, G. L. (2001). Paradoxical reduction of synaptic inhibition by vigabatrin. Journal of Neurophysiology, 86, 596–603.
Puia, G., Vicini, S., Seeburg, P. H., & Costa, E. (1991). Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl− currents. Molecular Pharmacology, 39, 691–696.
Rae, C., Hare, N., Bubb, W. A., McEwan, S. R., Bröer, A., McQuillan, J. A., et al. (2003). Inhibition of glutamine transport depletes glutamate and GABA neurotransmitter pools: Further evidence for metabolic compartmentation. Journal of Neurochemistry, 85, 503–514.
Rae, C., Lawrance, M. L., Dias, L. S., Provis, T., Bubb, W. A., & Balcar, V. J. (2000). Strategies for studies of potentially neurotoxic mechanisms involving deficient transport of L-glutamate: Antisense knockout in rat brain in vivo and changes in the neurotransmitter metabolism following inhibition of glutamate transport in guinea pigs brain slices. Brain Research Bulletin, 53, 373–381.
Rae, C., Moussa, C. E.-H., Griffin, J. L., Bubb, W. A., Wallis, T., & Balcar, V. J. (2005). Group I and II metabotropic glutamate receptors alter brain cortical metabolic and glutamate/glutamine cycle activity: A 13C NMR spectroscopy and metabolomic study. Journal of Neurochemistry, 92, 405–416.
Rae, C., Moussa, C. E.-H., Griffin, J. L., Parekh, S. B., Bubb, W. A., Hunt, N. H., et al. (2006). A metabolomic approach to ionotropic glutamate receptor subtype function: A nuclear magnetic resonance in vitro investigation. Journal of Cerebral Blood Flow and Metabolism, 26, 1005–1017.
Rae, C., Nasrallah, F. A., Griffin, J. L., & Balcar, V. J. (2009). Now I know my ABC. A systems neurochemistry and functional metabolomic approach to understanding the GABAergic system. Journal of Neurochemistry, 109(Suppl 1), 109–116.
Rogawski, M. A., & Löscher, W. (2004). The neurobiology of antiepileptic drugs. Nature Reviews. Neuroscience, 5, 553–564.
Smith, M. D., Saunders, G. W., Clausen, R. P., Frølund, B., Krogsgaard-Larsen, P., Larsson, O. M., et al. (2008). Inhibition of the betaine-GABA transporter (mGAT2/BGT-1) modulates spontaneous electrographic bursting in the medial entorhinal cortex (mEC). Epilepsy Research, 79, 6–13.
Stanton, D., Liao, L. P., Moussa, C. E.-H., Rae, C., Bubb, W. A., & Balcar, V. J. (2003). Can inhibition of glutamate transport contribute to the action of neuroleptics? Psychaitrie (Prague), 7, 6–11.
Swinyard, E. A., White, H. S., Wolf, H. H., & Bondinell, W. E. (1991). Anticonvulsant profiles of the potent and orally active GABA uptake inhibitors SK and F 89976A and SK and F 100330A and 4 prototype antiepileptic drugs in mice and rats. Epilepsia, 32, 569–577.
Tagamets, M. A., & Horwitz, B. (2001). Interpreting PET and fMRI measures of functional neural activity: The effects of synaptic inhibition on cortical activation in human imaging studies. Brain Research Bulletin, 54, 267–273.
Tarasenko, A. S., Linetska, M. V., Storchak, L. G., & Himmelreich, N. H. (2006). Effectiveness of extracellular lactate/pyruvate for sustaining synaptic vesicle proton gradient generation and vesicular accumulation of GABA. Journal of Neurochemistry, 99, 787–796.
Trevelyan, A. J., Sussillo, D., & Yuste, R. (2007). Feedforward inhibition contributes to the control of epileptiform propagation speed. Journal of Neuroscience, 27, 3383–3387.
Wold, S. (1994). Exponentially weighted moving principal components analysis and projections to latent structures. Chemometrics and Intelligent Laboratory Systems., 23, 149–161.
Wu, Y., Wang, W. G., & Richerson, G. B. (2001). GABA transaminase inhibition induces spontaneous and enhances depolarization-evoked GABA efflux via reversal of the GABA transporter. Journal of Neuroscience, 21, 2630–2639.
Wu, Y., Wang, W., & Richerson, G. B. (2003). Vigabatrin induces tonic inhibition via GABA transporter reversal without increasing vesicular GABA release. Journal of Neurophysiology, 89, 2021–2034.
Yasumi, M., Sato, K., Shimada, S., Nishimura, M., & Tohyama, M. (1997). Regional distribution of GABA transporter 1 (GAT1) mRNA in the rat brain: Comparison with glutamic acid decarboxylase(67)(GAD(67))mRNA localization. Molecular Brain Research, 44, 205–218.
Zhu, X. M., & Ong, W. Y. (2004). A light and electron microscopic study of betaine/GABA transporter distribution in the monkey cerebral neocortex and hippocampus. Journal of Neurocytology, 33, 233–240.
Acknowledgements
This work was supported by UNSW (Goldstar award to CR), NewSouth Global and the Australian National Health and Medical Research Council (grant to CR and VJB). The authors are grateful to Ms. Adelle Shasta, and Dr. Donald Thomas of the UNSW Analytical centre for expert technical support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nasrallah, F.A., Balcar, V.J. & Rae, C. A metabonomic study of inhibition of GABA uptake in the cerebral cortex. Metabolomics 6, 67–77 (2010). https://doi.org/10.1007/s11306-009-0176-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11306-009-0176-0